Human Phenotype Ontology

Input	HPO ID	HPO term	Distance	Gene	Gene id entrez	DiseaseId	DiseaseName	Source	Typical association	ClinVar variants	HGNC ID	GeneMIM
HPO disease - gene - phenotype typical associations:
HP:0000834	HP:0000834	Abnormality of the adrenal glands	0	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0000834	Abnormality of the adrenal glands	0	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0011732	Abnormality of adrenal morphology	1	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0011733	Abnormality of adrenal physiology	1	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0011732	Abnormality of adrenal morphology	1	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0011733	Abnormality of adrenal physiology	1	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0011742	Ectopic adrenal gland	2	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0008242	Pseudohypoaldosteronism	2	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0008216	Adrenal gland dysgenesis	2	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0000849	Adrenocortical abnormality	2	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0008186	Adrenocortical cytomegaly	2	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0010512	Adrenal calcification	2	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0002717	Adrenal overactivity	2	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0008221	Adrenal hyperplasia	2	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0000846	Adrenal insufficiency	2	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0100631	Neoplasm of the adrenal gland	2	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0000835	Adrenal hypoplasia	2	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0008186	Adrenocortical cytomegaly	2	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0010512	Adrenal calcification	2	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0000846	Adrenal insufficiency	2	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0002717	Adrenal overactivity	2	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0008221	Adrenal hyperplasia	2	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0000835	Adrenal hypoplasia	2	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0100631	Neoplasm of the adrenal gland	2	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0000849	Adrenocortical abnormality	2	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0011742	Ectopic adrenal gland	2	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0008242	Pseudohypoaldosteronism	2	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0008216	Adrenal gland dysgenesis	2	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0008231	Macronodular adrenal hyperplasia	3	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0008207	Primary adrenal insufficiency	3	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0000859	Hyperaldosteronism	3	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0100642	Neoplasm of the adrenal medulla	3	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0008258	Congenital adrenal hyperplasia	3	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0011734	Central adrenal insufficiency	3	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0008244	Congenital adrenal hypoplasia	3	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0003118	Increased circulating cortisol level	3	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0100641	Neoplasm of the adrenal cortex	3	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0008239	Adrenal medullary hypoplasia	3	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0001580	Pigmented micronodular adrenocortical disease	3	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0011743	Adrenal gland agenesis	3	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0008182	Adrenocortical hypoplasia	3	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0011734	Central adrenal insufficiency	3	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0008244	Congenital adrenal hypoplasia	3	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0000859	Hyperaldosteronism	3	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0100642	Neoplasm of the adrenal medulla	3	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0008258	Congenital adrenal hyperplasia	3	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0008239	Adrenal medullary hypoplasia	3	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0001580	Pigmented micronodular adrenocortical disease	3	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0003118	Increased circulating cortisol level	3	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0100641	Neoplasm of the adrenal cortex	3	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0008182	Adrenocortical hypoplasia	3	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0011743	Adrenal gland agenesis	3	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0008231	Macronodular adrenal hyperplasia	3	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0008207	Primary adrenal insufficiency	3	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0011736	Primary hyperaldosteronism	4	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0001579	Primary hypercortisolism	4	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0006748	Adrenal pheochromocytoma	4	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0011735	Adrenocorticotropin deficient adrenal insufficiency	4	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0025436	Elevated serum 11-deoxycortisol	4	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0008256	Adrenocortical adenoma	4	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0011741	Secondary hyperaldosteronism	4	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0011738	Corticotropin-releasing hormone receptor defect	4	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0006744	Adrenocortical carcinoma	4	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0011737	Corticotropin-releasing hormone deficient adrenal insufficiency	4	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0008163	Decreased circulating cortisol level	4	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0011744	Secondary hypercortisolism	4	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0008259	Adrenocorticotropin receptor defect	4	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0004319	Decreased circulating aldosterone level	4	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0011738	Corticotropin-releasing hormone receptor defect	4	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0025436	Elevated serum 11-deoxycortisol	4	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0008256	Adrenocortical adenoma	4	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0011741	Secondary hyperaldosteronism	4	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0011737	Corticotropin-releasing hormone deficient adrenal insufficiency	4	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0006744	Adrenocortical carcinoma	4	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0008259	Adrenocorticotropin receptor defect	4	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0004319	Decreased circulating aldosterone level	4	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0008163	Decreased circulating cortisol level	4	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0011744	Secondary hypercortisolism	4	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0011735	Adrenocorticotropin deficient adrenal insufficiency	4	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0011736	Primary hyperaldosteronism	4	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0001579	Primary hypercortisolism	4	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0006748	Adrenal pheochromocytoma	4	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0011745	Non-secretory adrenocortical adenoma	5	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0011740	Glucocortocoid-insensitive primary hyperaldosteronism	5	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0011739	Dexamethasone-suppressible primary hyperaldosteronism	5	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0011746	Secretory adrenocortical adenoma	5	ANTXR2 CL E G H	118429	2176	Epimetaphyseal skeletal dysplasia	ORPHA	1	293	21732	608041
HP:0000834	HP:0011740	Glucocortocoid-insensitive primary hyperaldosteronism	5	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0011739	Dexamethasone-suppressible primary hyperaldosteronism	5	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0011746	Secretory adrenocortical adenoma	5	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HP:0000834	HP:0011745	Non-secretory adrenocortical adenoma	5	WNT4 CL E G H	54361	139466		ORPHA	1	73	12783	603490
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0000834	HP:0000834	Abnormality of the adrenal glands	0	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0000834	Abnormality of the adrenal glands	0	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0000834	Abnormality of the adrenal glands	0	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0000834	Abnormality of the adrenal glands	0	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0000834	Abnormality of the adrenal glands	0	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0000834	Abnormality of the adrenal glands	0	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0000834	Abnormality of the adrenal glands	0	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0011733	Abnormality of adrenal physiology	1	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0011732	Abnormality of adrenal morphology	1	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0011732	Abnormality of adrenal morphology	1	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0011733	Abnormality of adrenal physiology	1	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0011732	Abnormality of adrenal morphology	1	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0011733	Abnormality of adrenal physiology	1	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0011732	Abnormality of adrenal morphology	1	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0011733	Abnormality of adrenal physiology	1	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0011732	Abnormality of adrenal morphology	1	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0011733	Abnormality of adrenal physiology	1	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0011732	Abnormality of adrenal morphology	1	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0011733	Abnormality of adrenal physiology	1	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0011733	Abnormality of adrenal physiology	1	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0011732	Abnormality of adrenal morphology	1	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0100631	Neoplasm of the adrenal gland	2	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0000835	Adrenal hypoplasia	2	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0008242	Pseudohypoaldosteronism	2	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0008216	Adrenal gland dysgenesis	2	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0000849	Adrenocortical abnormality	2	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0011742	Ectopic adrenal gland	2	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0010512	Adrenal calcification	2	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0008186	Adrenocortical cytomegaly	2	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0008221	Adrenal hyperplasia	2	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0000846	Adrenal insufficiency	2	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0002717	Adrenal overactivity	2	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0008186	Adrenocortical cytomegaly	2	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0010512	Adrenal calcification	2	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0002717	Adrenal overactivity	2	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0008221	Adrenal hyperplasia	2	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0000846	Adrenal insufficiency	2	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0100631	Neoplasm of the adrenal gland	2	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0000835	Adrenal hypoplasia	2	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0011742	Ectopic adrenal gland	2	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0008242	Pseudohypoaldosteronism	2	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0008216	Adrenal gland dysgenesis	2	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0000849	Adrenocortical abnormality	2	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0000849	Adrenocortical abnormality	2	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0011742	Ectopic adrenal gland	2	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0008242	Pseudohypoaldosteronism	2	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0008216	Adrenal gland dysgenesis	2	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0008186	Adrenocortical cytomegaly	2	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0010512	Adrenal calcification	2	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0002717	Adrenal overactivity	2	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0008221	Adrenal hyperplasia	2	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0000846	Adrenal insufficiency	2	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0000835	Adrenal hypoplasia	2	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0100631	Neoplasm of the adrenal gland	2	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0010512	Adrenal calcification	2	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0008186	Adrenocortical cytomegaly	2	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0008221	Adrenal hyperplasia	2	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0000846	Adrenal insufficiency	2	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0002717	Adrenal overactivity	2	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0000835	Adrenal hypoplasia	2	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0100631	Neoplasm of the adrenal gland	2	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0008242	Pseudohypoaldosteronism	2	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0008216	Adrenal gland dysgenesis	2	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0000849	Adrenocortical abnormality	2	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0011742	Ectopic adrenal gland	2	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0002717	Adrenal overactivity	2	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0008221	Adrenal hyperplasia	2	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0000846	Adrenal insufficiency	2	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0100631	Neoplasm of the adrenal gland	2	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0000835	Adrenal hypoplasia	2	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0000849	Adrenocortical abnormality	2	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0011742	Ectopic adrenal gland	2	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0008242	Pseudohypoaldosteronism	2	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0008216	Adrenal gland dysgenesis	2	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0008186	Adrenocortical cytomegaly	2	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0010512	Adrenal calcification	2	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0008221	Adrenal hyperplasia	2	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0000846	Adrenal insufficiency	2	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0002717	Adrenal overactivity	2	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0000835	Adrenal hypoplasia	2	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0100631	Neoplasm of the adrenal gland	2	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0000849	Adrenocortical abnormality	2	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0011742	Ectopic adrenal gland	2	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0008242	Pseudohypoaldosteronism	2	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0008216	Adrenal gland dysgenesis	2	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0008186	Adrenocortical cytomegaly	2	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0010512	Adrenal calcification	2	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0000835	Adrenal hypoplasia	2	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0100631	Neoplasm of the adrenal gland	2	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0008216	Adrenal gland dysgenesis	2	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0000849	Adrenocortical abnormality	2	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0011742	Ectopic adrenal gland	2	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0008242	Pseudohypoaldosteronism	2	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0008186	Adrenocortical cytomegaly	2	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0010512	Adrenal calcification	2	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0008221	Adrenal hyperplasia	2	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0000846	Adrenal insufficiency	2	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0002717	Adrenal overactivity	2	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0011743	Adrenal gland agenesis	3	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0008182	Adrenocortical hypoplasia	3	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0008231	Macronodular adrenal hyperplasia	3	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0008207	Primary adrenal insufficiency	3	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0100642	Neoplasm of the adrenal medulla	3	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0008258	Congenital adrenal hyperplasia	3	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0011734	Central adrenal insufficiency	3	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0008244	Congenital adrenal hypoplasia	3	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0000859	Hyperaldosteronism	3	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0003118	Increased circulating cortisol level	3	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0100641	Neoplasm of the adrenal cortex	3	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0008239	Adrenal medullary hypoplasia	3	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0001580	Pigmented micronodular adrenocortical disease	3	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0000859	Hyperaldosteronism	3	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0100642	Neoplasm of the adrenal medulla	3	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0008258	Congenital adrenal hyperplasia	3	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0011734	Central adrenal insufficiency	3	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0008244	Congenital adrenal hypoplasia	3	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0001580	Pigmented micronodular adrenocortical disease	3	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0003118	Increased circulating cortisol level	3	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0100641	Neoplasm of the adrenal cortex	3	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0008239	Adrenal medullary hypoplasia	3	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0011743	Adrenal gland agenesis	3	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0008182	Adrenocortical hypoplasia	3	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0008207	Primary adrenal insufficiency	3	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0008231	Macronodular adrenal hyperplasia	3	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0008207	Primary adrenal insufficiency	3	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0008231	Macronodular adrenal hyperplasia	3	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0008244	Congenital adrenal hypoplasia	3	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0000859	Hyperaldosteronism	3	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0100642	Neoplasm of the adrenal medulla	3	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0008258	Congenital adrenal hyperplasia	3	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0011734	Central adrenal insufficiency	3	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0008239	Adrenal medullary hypoplasia	3	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0001580	Pigmented micronodular adrenocortical disease	3	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0003118	Increased circulating cortisol level	3	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0100641	Neoplasm of the adrenal cortex	3	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0008182	Adrenocortical hypoplasia	3	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0011743	Adrenal gland agenesis	3	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0100642	Neoplasm of the adrenal medulla	3	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0008258	Congenital adrenal hyperplasia	3	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0011734	Central adrenal insufficiency	3	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0008244	Congenital adrenal hypoplasia	3	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0000859	Hyperaldosteronism	3	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0008239	Adrenal medullary hypoplasia	3	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0001580	Pigmented micronodular adrenocortical disease	3	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0003118	Increased circulating cortisol level	3	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0100641	Neoplasm of the adrenal cortex	3	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0011743	Adrenal gland agenesis	3	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0008182	Adrenocortical hypoplasia	3	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0008231	Macronodular adrenal hyperplasia	3	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0008207	Primary adrenal insufficiency	3	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0001580	Pigmented micronodular adrenocortical disease	3	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0003118	Increased circulating cortisol level	3	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0100641	Neoplasm of the adrenal cortex	3	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0008239	Adrenal medullary hypoplasia	3	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0008182	Adrenocortical hypoplasia	3	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0011743	Adrenal gland agenesis	3	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0008207	Primary adrenal insufficiency	3	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0008231	Macronodular adrenal hyperplasia	3	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0000859	Hyperaldosteronism	3	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0100642	Neoplasm of the adrenal medulla	3	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0008258	Congenital adrenal hyperplasia	3	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0011734	Central adrenal insufficiency	3	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0008244	Congenital adrenal hypoplasia	3	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0008239	Adrenal medullary hypoplasia	3	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0001580	Pigmented micronodular adrenocortical disease	3	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0003118	Increased circulating cortisol level	3	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0100641	Neoplasm of the adrenal cortex	3	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0008182	Adrenocortical hypoplasia	3	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0011743	Adrenal gland agenesis	3	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0008231	Macronodular adrenal hyperplasia	3	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0008207	Primary adrenal insufficiency	3	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0008258	Congenital adrenal hyperplasia	3	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0011734	Central adrenal insufficiency	3	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0008244	Congenital adrenal hypoplasia	3	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0000859	Hyperaldosteronism	3	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0100642	Neoplasm of the adrenal medulla	3	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0011743	Adrenal gland agenesis	3	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0008182	Adrenocortical hypoplasia	3	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0008231	Macronodular adrenal hyperplasia	3	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0008207	Primary adrenal insufficiency	3	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0100642	Neoplasm of the adrenal medulla	3	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0008258	Congenital adrenal hyperplasia	3	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0011734	Central adrenal insufficiency	3	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0008244	Congenital adrenal hypoplasia	3	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0000859	Hyperaldosteronism	3	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0008239	Adrenal medullary hypoplasia	3	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0001580	Pigmented micronodular adrenocortical disease	3	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0003118	Increased circulating cortisol level	3	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0100641	Neoplasm of the adrenal cortex	3	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0011744	Secondary hypercortisolism	4	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0008259	Adrenocorticotropin receptor defect	4	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0004319	Decreased circulating aldosterone level	4	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0008163	Decreased circulating cortisol level	4	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0011736	Primary hyperaldosteronism	4	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0001579	Primary hypercortisolism	4	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0006748	Adrenal pheochromocytoma	4	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0011735	Adrenocorticotropin deficient adrenal insufficiency	4	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0025436	Elevated serum 11-deoxycortisol	4	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0008256	Adrenocortical adenoma	4	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0011741	Secondary hyperaldosteronism	4	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0011738	Corticotropin-releasing hormone receptor defect	4	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0006744	Adrenocortical carcinoma	4	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0011737	Corticotropin-releasing hormone deficient adrenal insufficiency	4	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0025436	Elevated serum 11-deoxycortisol	4	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0008256	Adrenocortical adenoma	4	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0011741	Secondary hyperaldosteronism	4	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0011738	Corticotropin-releasing hormone receptor defect	4	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0006744	Adrenocortical carcinoma	4	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0011737	Corticotropin-releasing hormone deficient adrenal insufficiency	4	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0004319	Decreased circulating aldosterone level	4	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0008163	Decreased circulating cortisol level	4	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0011744	Secondary hypercortisolism	4	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0008259	Adrenocorticotropin receptor defect	4	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0011736	Primary hyperaldosteronism	4	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0001579	Primary hypercortisolism	4	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0006748	Adrenal pheochromocytoma	4	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0011735	Adrenocorticotropin deficient adrenal insufficiency	4	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0011735	Adrenocorticotropin deficient adrenal insufficiency	4	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0011736	Primary hyperaldosteronism	4	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0001579	Primary hypercortisolism	4	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0006748	Adrenal pheochromocytoma	4	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0011738	Corticotropin-releasing hormone receptor defect	4	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0025436	Elevated serum 11-deoxycortisol	4	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0008256	Adrenocortical adenoma	4	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0011741	Secondary hyperaldosteronism	4	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0011737	Corticotropin-releasing hormone deficient adrenal insufficiency	4	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0006744	Adrenocortical carcinoma	4	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0008259	Adrenocorticotropin receptor defect	4	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0004319	Decreased circulating aldosterone level	4	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0008163	Decreased circulating cortisol level	4	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0011744	Secondary hypercortisolism	4	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0011741	Secondary hyperaldosteronism	4	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0011738	Corticotropin-releasing hormone receptor defect	4	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0025436	Elevated serum 11-deoxycortisol	4	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0008256	Adrenocortical adenoma	4	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0006744	Adrenocortical carcinoma	4	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0011737	Corticotropin-releasing hormone deficient adrenal insufficiency	4	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0011744	Secondary hypercortisolism	4	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0008259	Adrenocorticotropin receptor defect	4	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0004319	Decreased circulating aldosterone level	4	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0008163	Decreased circulating cortisol level	4	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0006748	Adrenal pheochromocytoma	4	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0011735	Adrenocorticotropin deficient adrenal insufficiency	4	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0011736	Primary hyperaldosteronism	4	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0001579	Primary hypercortisolism	4	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0006744	Adrenocortical carcinoma	4	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0011737	Corticotropin-releasing hormone deficient adrenal insufficiency	4	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0004319	Decreased circulating aldosterone level	4	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0008163	Decreased circulating cortisol level	4	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0011744	Secondary hypercortisolism	4	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0008259	Adrenocorticotropin receptor defect	4	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0011736	Primary hyperaldosteronism	4	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0001579	Primary hypercortisolism	4	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0006748	Adrenal pheochromocytoma	4	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0011735	Adrenocorticotropin deficient adrenal insufficiency	4	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0011738	Corticotropin-releasing hormone receptor defect	4	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0025436	Elevated serum 11-deoxycortisol	4	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0008256	Adrenocortical adenoma	4	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0011741	Secondary hyperaldosteronism	4	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0011737	Corticotropin-releasing hormone deficient adrenal insufficiency	4	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0006744	Adrenocortical carcinoma	4	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0008259	Adrenocorticotropin receptor defect	4	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0004319	Decreased circulating aldosterone level	4	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0008163	Decreased circulating cortisol level	4	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0011744	Secondary hypercortisolism	4	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0011735	Adrenocorticotropin deficient adrenal insufficiency	4	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0011736	Primary hyperaldosteronism	4	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0001579	Primary hypercortisolism	4	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0006748	Adrenal pheochromocytoma	4	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0011738	Corticotropin-releasing hormone receptor defect	4	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0025436	Elevated serum 11-deoxycortisol	4	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0008256	Adrenocortical adenoma	4	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0011741	Secondary hyperaldosteronism	4	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0008259	Adrenocorticotropin receptor defect	4	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0004319	Decreased circulating aldosterone level	4	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0008163	Decreased circulating cortisol level	4	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0011744	Secondary hypercortisolism	4	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0006748	Adrenal pheochromocytoma	4	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0011735	Adrenocorticotropin deficient adrenal insufficiency	4	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0011736	Primary hyperaldosteronism	4	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0001579	Primary hypercortisolism	4	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0011738	Corticotropin-releasing hormone receptor defect	4	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0025436	Elevated serum 11-deoxycortisol	4	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0008256	Adrenocortical adenoma	4	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0011741	Secondary hyperaldosteronism	4	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0011737	Corticotropin-releasing hormone deficient adrenal insufficiency	4	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0006744	Adrenocortical carcinoma	4	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0011739	Dexamethasone-suppressible primary hyperaldosteronism	5	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0011746	Secretory adrenocortical adenoma	5	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0011745	Non-secretory adrenocortical adenoma	5	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0011740	Glucocortocoid-insensitive primary hyperaldosteronism	5	BTNL2 CL E G H	56244	797		ORPHA	0	30	1142	606000
HP:0000834	HP:0011740	Glucocortocoid-insensitive primary hyperaldosteronism	5	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0011739	Dexamethasone-suppressible primary hyperaldosteronism	5	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0011746	Secretory adrenocortical adenoma	5	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0011745	Non-secretory adrenocortical adenoma	5	CHD7 CL E G H	55636	138		ORPHA	0	2930	20626	608892
HP:0000834	HP:0011745	Non-secretory adrenocortical adenoma	5	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0011740	Glucocortocoid-insensitive primary hyperaldosteronism	5	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0011739	Dexamethasone-suppressible primary hyperaldosteronism	5	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0011746	Secretory adrenocortical adenoma	5	HLA-DRB1 CL E G H	3123	797		ORPHA	0	41	4948	142857
HP:0000834	HP:0011740	Glucocortocoid-insensitive primary hyperaldosteronism	5	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0011746	Secretory adrenocortical adenoma	5	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0011739	Dexamethasone-suppressible primary hyperaldosteronism	5	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0011745	Non-secretory adrenocortical adenoma	5	POLR1C CL E G H	9533	861		ORPHA	0	1944	20194	610060
HP:0000834	HP:0011740	Glucocortocoid-insensitive primary hyperaldosteronism	5	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0011739	Dexamethasone-suppressible primary hyperaldosteronism	5	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0011746	Secretory adrenocortical adenoma	5	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0011745	Non-secretory adrenocortical adenoma	5	POLR1D CL E G H	51082	861		ORPHA	0	111	20422	613715
HP:0000834	HP:0011740	Glucocortocoid-insensitive primary hyperaldosteronism	5	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0011739	Dexamethasone-suppressible primary hyperaldosteronism	5	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0011746	Secretory adrenocortical adenoma	5	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0011745	Non-secretory adrenocortical adenoma	5	SEMA3E CL E G H	9723	138		ORPHA	0	594	10727	608166
HP:0000834	HP:0011739	Dexamethasone-suppressible primary hyperaldosteronism	5	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0011746	Secretory adrenocortical adenoma	5	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0011745	Non-secretory adrenocortical adenoma	5	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847
HP:0000834	HP:0011740	Glucocortocoid-insensitive primary hyperaldosteronism	5	TCOF1 CL E G H	6949	861		ORPHA	0	695	11654	606847